Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Nieva

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Thrombosis and Haemostasis|March 6, 2007
The clinical significance of circulating tissue factor in prostate cancerJorge Nieva
Leukemia & Lymphoma|April 25, 2007
Understanding hairy cell leukemia geneticsJorge Nieva, Alan Saven
British Journal of Cancer|May 11, 2018
When it comes to genomic analysis of tumours, don't buy in bulkJorge Nieva, James Hicks
Translational Lung Cancer Research|March 10, 2023
Understanding KRAS for better targetingRonak Patel, Jorge Nieva
Trends in Biochemical Sciences|May 8, 2004
The antibody-catalyzed water oxidation pathway--a new chemical arm to immune defense?Jorge Nieva, Paul Wentworth
Leukemia Research|December 5, 2003
Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biologyJorge Nieva, Alan Saven
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 15, 2021
Clinical management of immune-related adverse events following immunotherapy treatment in patients with non-small cell lung cancerHannah Elizabeth Green, Jorge Nieva
Translational Lung Cancer Research|September 15, 2017
Biophysical technologies for understanding circulating tumor cell biology and metastasisDerrick W Su, Jorge Nieva
Blood|March 29, 2003
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemiaJorge Nieva, Kelly Bethel, Alan Saven
Journal of Cancer Policy|May 23, 2022
Effect of sponsor on enrollment criteria in non-small cell lung cancer clinical trialsRyan A Cooper, Yan Chai, Jorge Nieva
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Thrombosis and Haemostasis|March 6, 2007
The clinical significance of circulating tissue factor in prostate cancerJorge Nieva
Leukemia & Lymphoma|April 25, 2007
Understanding hairy cell leukemia geneticsJorge Nieva, Alan Saven
British Journal of Cancer|May 11, 2018
When it comes to genomic analysis of tumours, don't buy in bulkJorge Nieva, James Hicks
Translational Lung Cancer Research|March 10, 2023
Understanding KRAS for better targetingRonak Patel, Jorge Nieva
Trends in Biochemical Sciences|May 8, 2004
The antibody-catalyzed water oxidation pathway--a new chemical arm to immune defense?Jorge Nieva, Paul Wentworth
Leukemia Research|December 5, 2003
Cladribine activity in systemic mast cell disease: application of biochemistry in the modern era of molecular biologyJorge Nieva, Alan Saven
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 15, 2021
Clinical management of immune-related adverse events following immunotherapy treatment in patients with non-small cell lung cancerHannah Elizabeth Green, Jorge Nieva
Translational Lung Cancer Research|September 15, 2017
Biophysical technologies for understanding circulating tumor cell biology and metastasisDerrick W Su, Jorge Nieva
Blood|March 29, 2003
Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemiaJorge Nieva, Kelly Bethel, Alan Saven
Journal of Cancer Policy|May 23, 2022
Effect of sponsor on enrollment criteria in non-small cell lung cancer clinical trialsRyan A Cooper, Yan Chai, Jorge Nieva
Pageof 10